Ergo Science logo

ERGN - Ergo Science Share Price

$10800 0.0  0.0%

Last Trade - 24/12/19

Consumer Cyclicals
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £19.6m
Position in Universe th / 6395
Unlock ERGN Revenue
Relative Strength (%)
1m +0.65%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2001 2002 2003 2004 2005 2006 2007E 2008E CAGR / Avg
0.000 0.000 39.6 36.9 35.0 30.7
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2007, Ergo Science Corporation revenues decreased 38% to $8.4M. Net loss decreased 52% to $1.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Other Income increase from $0K to $441K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$5117.09 to -$2466.52.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ERGN Revenue Unlock ERGN Revenue

Net Income

ERGN Net Income Unlock ERGN Revenue

Normalised EPS

ERGN Normalised EPS Unlock ERGN Revenue

PE Ratio Range

ERGN PE Ratio Range Unlock ERGN Revenue

Dividend Yield Range

ERGN Dividend Yield Range Unlock ERGN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ERGN EPS Forecasts Unlock ERGN Revenue
Profile Summary

Ergo Science Corporation (Ergo) is a business information provider serving key markets from defense and communications to travel and horticulture, using an increasing range of media, through its wholly owned subsidiary, Nexus Media Communications (Nexus Media). In addition to core magazine brands, Ergo also provides services, which include exhibitions, conferences, awards ceremony events and online services. The Company's business includes 13 trade names; 150 domain names; approximately 50 printed magazines and directories, and approximately 30 Events, including exhibitions, awards evenings and conferences.

Last Annual December 31st, 2006
Last Interim June 30th, 2007
Incorporated May 1, 2001
Public Since December 14, 1995
No. of Shareholders: n/a
No. of Employees: 240
Sector Consumer Cyclicals
Industry Hotels & Entertainment Services
Exchange OTC Markets Group
Shares in Issue 581
Free Float (0.0%)
Eligible for
ERGN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ERGN
Upcoming Events for ERGN
Frequently Asked Questions for Ergo Science
What is the Ergo Science share price?

As of 24/12/19, shares in Ergo Science are trading at $10800, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Ergo Science share price performed this year?

Shares in Ergo Science are currently trading at $10800 and the price has moved by 20% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Ergo Science price has moved by 9.05% over the past year.

What are the analyst and broker recommendations for Ergo Science?

There are no analysts currently covering Ergo Science.

When will Ergo Science next release its financial results?

Ergo Science is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2008-06-30
What is the Ergo Science dividend yield?

Ergo Science does not currently pay a dividend.

Does Ergo Science pay a dividend?

Ergo Science does not currently pay a dividend.

When does Ergo Science next pay dividends?

Ergo Science does not currently pay a dividend.

How do I buy Ergo Science shares?

To buy shares in Ergo Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Ergo Science?

Shares in Ergo Science are currently trading at $10800, giving the company a market capitalisation of £n/a.

Where are Ergo Science shares listed? Where are Ergo Science shares listed?

Here are the trading details for Ergo Science:

Country of listing: United States
Exchange: OTC
Ticker Symbol: ERGN
What kind of share is Ergo Science?

We were not able to load our ranking data for Ergo Science

Is there a Ergo Science share price forecast 2020?

We were not able to load any forecast data for Ergo Science.

How can I tell whether the Ergo Science share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ergo Science. Over the past six months, the relative strength of its shares against the market has been 8.18%. At the current price of $10800, shares in Ergo Science are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Ergo Science PE Ratio?

We were not able to find PE ratio data for Ergo Science.

Who are the key directors of Ergo Science?

Ergo Science's management team is headed by:

William Comfort - DRC
Charles Finelli - PRE
Ling Kwok - VPR
Robin Dummett - DRC
Who are the major shareholders of Ergo Science?

Here are the top five shareholders of Ergo Science based on the size of their shareholding:

Similar to ERGN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.